Tested Applications
| Positive WB detected in | mouse skin tissue |
| Positive IHC detected in | human skin tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive FC (Intra) detected in | Jurkat cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 ul suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26025-1-AP targets CHRNA9 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag23272 Product name: Recombinant human CHRNA9 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 324-479 aa of BC113549 Sequence: HFCGAEARPVPHWARVVILKYMSRVLFVYDVGESCLSPHHSRERDHLTKVYSKLPESNLKAARNKDLSRKKDMNKRLKNDLGCQGKNPQEAESYCAQYKVLTRNIEYIAKCLKDHKATSSKGSEWKKVAKVIDRFFMWIFFIMVFVMTILIIARAD Predict reactive species |
| Full Name | cholinergic receptor, nicotinic, alpha 9 |
| Calculated Molecular Weight | 479 aa, 55 kDa |
| Observed Molecular Weight | 50-55 kDa |
| GenBank Accession Number | BC113549 |
| Gene Symbol | CHRNA9 |
| Gene ID (NCBI) | 55584 |
| RRID | AB_2880341 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UGM1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CHRNA9 (nicotinic α9 subunit of cholinergic receptor) gene is located in zone 4 (4p14) of short arm 1 of human chromosome 4, encoding a ligand-gated divalent cation channel protein, belonging to the nicotinic acetylcholine receptor (nAChR) superfamily. This subunit can be combined with CHRNA10 subunit to form a heteropentamer or a homopentamer, which is mainly distributed in cochlear outer hair cells, dorsal root ganglion, keratinocytes and immune cells.
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for CHRNA9 antibody 26025-1-AP | Download protocol |
| IHC protocol for CHRNA9 antibody 26025-1-AP | Download protocol |
| WB protocol for CHRNA9 antibody 26025-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
I'll search for the citations for catalog number 26025-1-AP.CHRNA9 Polyclonal antibody (26025-1-AP) has a total of 4 citations.
The citations appear in the following journals:
- Mar Drugs (2 publications, 2020) — breast cancer research on nicotine acetylcholine receptors and antitumor activity of αO-Conotoxin GeXIVA.
- Arch Biochem Biophys (2026) — colorectal cancer metastasis involving tsRNA-10547 and CHRNA9 suppression.
- Nat Commun (2026) — hepatocellular carcinoma progression via a hypothalamic vagal circuit (mouse).
The research fields span breast cancer, colorectal cancer, and hepatocellular carcinoma oncology studies.
| Species | Application | Title |
|---|---|---|
Mar Drugs αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.
| ||
Mar Drugs Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA. | ||
Arch Biochem Biophys tsRNA-10547 generated by m(1)A modification-mediated tRNA shearing promotes colorectal cancer metastasis via suppressing CHRNA9. | ||
Nat Commun Chronic stress activates a hypothalamic vagal circuit to promote hepatocellular carcinoma progression in male mice. |







